Oral ST1481 in Adults With Malignant Glioma: a Phase I-II Clinical Trial.
Latest Information Update: 18 Jul 2013
At a glance
- Drugs Gimatecan (Primary)
- Indications Anaplastic astrocytoma; Glioblastoma; Glioma; Oligodendroglioma
- Focus Adverse reactions; Therapeutic Use
- 15 Jul 2013 Planned number of patients changed from 59 to 83 as reported by ClinicalTrials.gov (NCT00087061).
- 15 Jul 2013 Planned number of patients changed from 59 to 83 as reported by ClinicalTrials.gov (NCT00087061).
- 15 Jul 2013 Additional trial identifier (NCT00087061) identified as reported by ClinicalTrials.gov.